| Members |
targetComponentId |
| Hypnotic |
Hypnotic agent (substance) |
| Hypnotic agent |
Hypnotic agent (substance) |
| Hypnotic dependence with current use |
Hypnotic dependence (disorder) |
| Hypnotic withdrawal syndrome without complication |
Hypnotic withdrawal |
| Hypoactive sexual desire disorder |
Lack or loss of sexual desire |
| Hypoalphaglobulinemia |
Hypoalphaglobulinaemia |
| Hypobetaglobulinemia |
Hypoalphaglobulinaemia |
| Hypoglobulinemia |
Hypoglobulinaemia |
| Hypoglycaemia unspecified |
Hypoglycaemia |
| Hypoglycemia clinical management plan |
Hypoglycemia clinical management plan (record artifact) |
| Hypoglycemia self management plan |
Hypoglycaemia self management plan |
| Hypoglycemia unspecified |
Hypoglycaemia |
| Hypoglycemia unspecified NOS |
Hypoglycaemia |
| hypogonadisme, diabetes mellitus, alopeci, mental retardering og elektrokardiografiske anomalier |
Woodhouse-Sakati syndrome is a multisystemic disorder with characteristics of hypogonadism, alopecia, diabetes mellitus, intellectual deficit and extrapyramidal signs with choreoathetoid movements and dystonia. The onset is usually in adolescence. Additional manifestations may include sensorineural deafness, flattened T waves on ECG, seizures, sensory polyneuropathy, dysarthria, various craniofacial abnormalities (high forehead, flat occiput, triangular face, prominent nasal root, hypertelorism, and down-slanting palpebral fissures), scoliosis, hyperreflexia, and camptodactyly. Associated with mutations in the DCAF17 gene (2q31.1), encoding a nucleolar protein of unknown function. The disease is transmitted in an autosomal recessive manner. |
| fund vedr. hypopharynx udtrykt ved TNM-systemet |
American Joint Committee on Cancer allowable value |
| Hypophysectomy by other specified approach |
Hypophysectomy |
| Hyposensitivity |
Hyposensitivity |
| glandulær hypospadi |
Glanular hypospadias |
| Hypospadias, hypertelorism, coloboma, deafness syndrome |
Branchioskeletogenital syndrome is a rare multiple congenital anomalies/dysmorphic syndrome characterized by moderate intellectual disability, distinctive craniofacial features (including brachycephaly, facial asymmetry, marked hypertelorism, blepharochalasis, proptosis, a broad nose with concave nasal ridge and bulbous nasal tip, midface hypoplasia, bifid uvula or partial cleft palate, and prognathism), progressive dental anomalies (dentigerous cysts, radicular dentin dysplasia and early tooth loss), vertebral fusions (particularly of C2-C3), and hypospadias. Hearing loss is an additional observed feature. |
| Hypotension NOS |
Low blood pressure |
| Hypotension NOS |
Low blood pressure |
| blodtrykssænkende middel |
Hypotensive agent (substance) |
| klinisk behandlingsplan for hypotyroidisme |
Hypothyroidism clinical management plan |
| Hypotonisk duodenografi |
Fluoroscopic hypotonic duodenography |
| allergi over for øjendråber indeholdende hypromellose |
Allergy to hypromellose |
| Hysterectomy NOS |
Hysterectomy |
| Hysterektomi, ikke nærmere specificeret |
Hysterectomy |
| hysterisk katapleksi |
Cataplexy |
| Hysterisk gang |
Functional gait abnormality |
| Hysterogram |
Fluoroscopic hysterography with contrast (procedure) |
| Hysterografi |
Fluoroscopic hysterography with contrast (procedure) |
| hysterosalpingografi |
Fluoroscopic hysterosalpingography with contrast (procedure) |
| Hysterosalpingogram |
Fluoroscopic hysterosalpingography with contrast (procedure) |
| Hysterosalpingogram |
Fluoroscopic hysterosalpingography with contrast (procedure) |
| abnormt fund ved hysterosalpingografi |
Fluoroscopic hysterosalpingography with contrast abnormal (finding) |
| Hysterosalpingogram abnormal |
Fluoroscopic hysterosalpingography with contrast abnormal (finding) |
| Hysterosalpingogram normal |
Fluoroscopic hysterosalpingography with contrast normal (finding) |
| normalt fund ved hysterosalpingografi |
Fluoroscopic hysterosalpingography with contrast normal (finding) |
| Hysterosalpingogram requested |
Fluoroscopic hysterosalpingography with contrast requested (situation) |
| hysterosalpingografi bestilt |
Fluoroscopic hysterosalpingography with contrast requested (situation) |
| hysterosalpingografi med positiv kontrast |
Fluoroscopic hysterosalpingography with contrast (procedure) |
| Hysterosalpingography |
Fluoroscopic hysterosalpingography with contrast (procedure) |
| Hysterosalpingografi, ikke nærmere specificeret |
Fluoroscopic hysterosalpingography with contrast (procedure) |
| Hysterosalpingography NOS |
Fluoroscopic hysterosalpingography with contrast (procedure) |
| Hysterosalpingografi med gaskontrast |
Fluoroscopic hysterosalpingography with contrast (procedure) |
| Hysterosalpingography with positive contrast |
Fluoroscopic hysterosalpingography with contrast (procedure) |
| Ichthyosis hystrix med døvhed |
A rare congenital ectodermal disorder characterized by vascularizing keratitis, hyperkeratotic skin lesions and hearing loss. Patients usually present at birth with generalized erythema and ichthyosiform scaling. The skin manifestations are progressive with erythrokeratoderma characterized by well-demarcated erythematous and keratotic plaques with a verrucous appearance predominantly located on the face, scalp, ears, elbows and knees. Hearing loss is congenital, usually sensorineural and is often profound. Caused by mutations involving the N-terminus and first extracellular loop of the GJB2 gene (13q11-q12), encoding connexin-26. Most of the reported cases are sporadic, but familial cases with autosomal dominant inheritance have been reported. |
| I-V pyelography - general NOS |
Intravenous pyelogram |
| I-V pyelography - general NOS |
Intravenous pyelogram |
| IUD - NOS |
Intrauterine contraceptive device |
| IUD in situ from other agency |
Intrauterine contraceptive device in situ (finding) |
| IV sclerosing injection NOS |
Injection of sclerosing agent |
| Iatrogen tatovering |
Iatrogenic tattoo |
| Ibandronic acid 1mg/mL injection solution 2mL vial |
Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ibandronic acid 1mg/mL injection solution 3mL prefilled syringe |
Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ibandronic acid 1mg/mL injection solution 6mL vial |
Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| ibandronsyre 1 mg/ml koncentrat til intravenøs infusion |
Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ibandronic acid 1mg/mL intravenous infusion conc |
Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| ibuprofen 40 mg/ml orale dråber |
Ibuprofen 40 mg/mL oral suspension |
| ibuprofen 100 mg + pseudoephedrin 15 mg 5 ml oral suspension |
Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Ichthyobodo nector |
Ichthyobodo necator (organism) |
| Ichthyosis hystrix gravior, Rheydts type |
A rare congenital ectodermal disorder characterized by vascularizing keratitis, hyperkeratotic skin lesions and hearing loss. Patients usually present at birth with generalized erythema and ichthyosiform scaling. The skin manifestations are progressive with erythrokeratoderma characterized by well-demarcated erythematous and keratotic plaques with a verrucous appearance predominantly located on the face, scalp, ears, elbows and knees. Hearing loss is congenital, usually sensorineural and is often profound. Caused by mutations involving the N-terminus and first extracellular loop of the GJB2 gene (13q11-q12), encoding connexin-26. Most of the reported cases are sporadic, but familial cases with autosomal dominant inheritance have been reported. |
| icodextrin 7,5 % peritonealdialysevæske |
Icodextrin only product |
| neonatal icterus, uspecificeret |
Neonatal jaundice |
| Idiopatisk benign kutan mucinose |
Localized lichen myxedematosus |
| Idiopatisk interstitiel pneumoni |
Idiopathic pulmonary fibrosis (disorder) |
| Idiopathic fibrosing alveolitis NOS |
Idiopathic pulmonary fibrosis (disorder) |
| Idiopatisk hypertrofisk subaortisk stenose |
Hypertrophic obstructive cardiomyopathy |
| Idiopathic hypertrophic subaortic stenosis |
Hypertrophic obstructive cardiomyopathy |
| Idiopathic multifocal fibrosclerosis, NEC |
Multifocal fibrosclerosis |
| idiopatisk osteoporose med patologisk fraktur |
Osteoporotic fracture due to idiopathic osteoporosis (disorder) |
| Idiopathic proctocolitis |
Proctocolitis (disorder) |
| Idiopathic purpura |
Immune thrombocytopenia |
| Idiopathic respiratory distress syndrome |
Respiratory distress syndrome in the newborn |
| Idiopathic retroperitoneal fibrosis |
Retroperitoneal fibrosis |
| Idiopathic thrombocythemia |
Essential thrombocythemia |
| Idiopatisk drengepigethed |
Gender identity finding |
| Idiosynkratisk intoksikation |
Aggression caused by ethanol (finding) |
| Idoxuridine 0.1% |
Idoxuridine 1 mg/mL eye solution |
| Iliofemoral vascular bypass |
Iliofemoral shunt |
| Ilium X-ray |
Plain X-ray of ilium (procedure) |
| røntgenundersøgelse af os ilium |
Plain X-ray of ilium (procedure) |
| Ilium X-ray |
Plain X-ray of ilium (procedure) |
| dårligt definerede frakturer af overekstremitet |
Fracture of multiple bones of upper limb |
| dårligt defineret infektionssygdom |
Infectious disease |
| Dårligt defineret intestinal infektion |
Intestinal infectious disease |
| dårligt defineret topografisk lokalisation |
Body region structure |
| Illegal abort, fuldstændig |
Termination of pregnancy |
| Illegal abortion complicated by cardiac arrest |
Induced termination of pregnancy complicated by cardiac arrest |
| Illegal abortion complicated by cardiac failure |
Induced termination of pregnancy complicated by cardiac failure |
| Illegal abort kompliceret af skader på bækkenorganer OG/ELLER -væv |
Induced termination of pregnancy complicated by damage to pelvic organs and/or tissues (disorder) |
| Illegal abort kompliceret af forsinket OG/ELLER kraftig blødning |
Excessive hemorrhage due to and following induced termination of pregnancy (disorder) |
| Illegal abort kompliceret af emboli |
Induced termination of pregnancy complicated by embolism (disorder) |
| Illegal abort kompliceret af underlivsbetændelse |
Induced termination of pregnancy complicated by genital-pelvic infection (disorder) |
| Illegal abortion complicated by genital-pelvic infection |
Induced termination of pregnancy complicated by genital-pelvic infection (disorder) |
| Illegal abort kompliceret af stofskiftesygdom |
Induced termination of pregnancy complicated by metabolic disorder (disorder) |
| illegal abort kompliceret af nyreinsufficiens |
Induced termination of pregnancy complicated by renal failure (disorder) |
| Illegal abort kompliceret af shock |
Induced termination of pregnancy complicated by shock |
| Illegal abort, ufuldstændig |
Incomplete induced termination of pregnancy |
| Illegal abort, uspecificeret |
Termination of pregnancy |
| Illegal abort med akut nyresvigt |
Induced termination of pregnancy complicated by acute renal failure (disorder) |
FHIR